Good Safety, Effiacy With Novel Drug-Filled Stent

ACC Conference Reporter

TCT 2016 | Washington, DC — A polymer-free drug-filled stent — designed to shorten dual antiplatelet therapy (DAPT) — exhibited low adverse event rates in early data from the RevElution trial, a researcher said here. Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings